Partner
Xu Ya Jun
Managing Partner, Hongsen Investment Group
- Firm
- Hongsen Investment Group
- Title
- Managing Partner
- Role
- Managing partner
- Known as
- Investor
Claim, correct or request removal
Record updated 22 September 2026
About
Dr. Xu is a co-founder of Epimab Biotherapeutics. Dr. Xu had held senior scientific positions at various global world-class pharmaceutical and healthcare companies including ChemPartner, Millennium Pharmaceutical and BASF/Abbott.
Background
- Education
- Dr. Xu holds Bachelor’s and Master’s degrees in Chemistry from the Beijing University of Chemical Technology, and a PhD in Biochemistry from Brandeis University. Dr. Xu had three years of Postdoctoral training at Harvard school of Public Health in department of Cell Biology, Endocrinology and Molecular Toxicology.Source (opens in a new tab)
Is this you? Remove my profile
Loading relationship preview